Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.73%7.95B | 30.58%6.93B | 31.22%2B | 38.11%1.86B | 25.53%1.58B | 26.52%1.48B | 45.67%5.31B | 37.57%1.53B | 47.30%1.35B | 1.26B |
| Cost of revenue | 12.20%4.41B | 20.45%3.93B | 19.97%1.11B | 25.46%1.04B | 11.54%877.91M | 25.01%901.55M | 60.30%3.26B | 53.14%921.68M | 58.99%830.44M | 787.11M |
| Gross profit | 18.03%3.54B | 46.74%3B | 48.35%897.76M | 58.37%821.24M | 48.96%700.13M | 28.94%582.39M | 27.16%2.05B | 19.13%605.18M | 31.78%518.55M | 470.03M |
| Operating expense | 9.51%2.46B | 25.55%2.24B | 39.35%682.98M | 23.65%522.21M | 24.74%494.3M | 13.79%544.65M | 32.17%1.79B | 0.87%490.11M | 41.48%422.34M | 396.27M |
| Operating profit | 43.30%1.09B | 193.50%757.38M | 86.64%214.78M | 210.82%299.03M | 179.08%205.84M | 239.86%37.74M | 0.74%258.06M | 419.89%115.07M | 1.31%96.21M | 73.76M |
| Net non-operating interest income (expenses) | -17.82%-7.34M | -87.28%-6.23M | -189.99%-2.17M | -192.19%-2.36M | -12.00%-961K | 19.08%-738K | 24.10%-3.33M | 23.34%-749K | 25.83%-807K | -858K |
| Non-operating interest income | 7,563.64%843K | -8.33%11K | 0.00%6K | --0 | ---- | ---- | -76.00%12K | 20.00%6K | --0 | ---- |
| Non-operating interest expense | 31.12%8.18M | 86.94%6.24M | 188.48%2.18M | 192.19%2.36M | 11.81%966K | -19.08%738K | -24.68%3.34M | -23.12%755K | -25.83%807K | --864K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 508K | |||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 111.74%73K | -677.50%-622K | 85.64%-80K | |||||||
| Less:Other special charges | -111.74%-73K | 677.50%622K | ---- | ---- | ---- | ---- | -85.64%80K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 382.25%3.26M | 96.51%676K | 713K | -478K | 59K | 1,132.26%382K | 103.05%344K | 0 | ||
| Income before tax | 44.01%1.08B | 194.60%751.2M | 86.18%212.7M | 209.35%296.19M | 181.25%204.94M | 234.16%37.38M | 6.26%254.99M | 481.21%114.24M | 11.90%95.75M | 72.87M |
| Income tax | 16.19%361.03M | 856.36%310.73M | 2,063.97%139.76M | 249.04%94.04M | 221.22%65.86M | 241.24%11.07M | 222.95%32.49M | 88.11%-7.12M | 107.43%26.94M | 20.5M |
| Net income | 63.64%720.79M | 97.96%440.47M | -39.90%72.94M | 193.81%202.15M | 165.61%139.07M | 231.39%26.31M | -16.48%222.5M | 52.60%121.36M | -5.19%68.8M | 52.36M |
| Net income continuous operations | 63.64%720.79M | 97.96%440.47M | -39.90%72.94M | 193.81%202.15M | 165.60%139.07M | 231.39%26.31M | -16.48%222.5M | 52.60%121.36M | -5.19%68.8M | --52.36M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 63.64%720.79M | 97.96%440.47M | -39.90%72.94M | 193.81%202.15M | 165.61%139.07M | 231.39%26.31M | -16.48%222.5M | 52.60%121.36M | -5.19%68.8M | 52.36M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 63.64%720.79M | 97.96%440.47M | -39.90%72.94M | 193.81%202.15M | 165.61%139.07M | 231.39%26.31M | -16.48%222.5M | 52.60%121.36M | -5.19%68.8M | 52.36M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 61.82%118.81 | 94.39%73.42 | -41.40%12.0403 | 188.32%33.7297 | 159.70%23.24 | 228.76%4.41 | -23.84%37.77 | 48.52%20.5476 | -14.68%11.6986 | 8.9489 |
| Diluted earnings per share | 63.57%112.78 | 96.61%68.95 | -40.71%11.345 | 191.80%31.675 | 144.89%21.795 | 220.73%4.135 | -21.95%35.07 | 59.86%19.135 | -14.98%10.855 | 8.8999 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |